Continuing Medical Education for Nurse Practitioners | Earn CME Credit

Education

Search

Saved Activities

0 Activities

0 Activities

Filter Content

Page 6 of 7

Results 376 - 450 of 503

9907-0001_guidelines

How to Use IPF Guidelines to Make a Diagnosis

Atopic Dermatitis: Diagnosis and Management in Infants and Children

Updates in Atopic Dermatitis: Diagnosis and Management in Adults

Are You Ready for Gene Replacement Therapy?

The Changing Landscape of SMA–Updates from Anaheim, CA

A History of Hemophilia Treatment: Factor Replacement to Gene Therapy

Getting to Know Gene Therapy: Terminology and Concepts

New_Concepts_in_the_Pathobiology_of_Asthma_264x150

New Concepts in the Pathobiology of Asthma

When Is a Cough Not Just a Cough?

Diagnosing ILDs Such as IPF and More

Beyond the Basics: Complex ILD Cases

PowerPoint Slides: Achieving Better Control of Severe Asthma

Updates in Atopic Dermatitis: The Allergist’s Guide to Optimizing Care - Child

Updates in Atopic Dermatitis: The Allergist’s Guide to Optimizing Care - Adult

U.S. Presidents with Severe Asthma: Endotypes and Precision Medicine

Urgency for Early Diagnosis and Treatment of SMA

sma-journal-icon_263x0

Gene Therapy for SMA: An Emerging Treatment Option for a Devastating Disease

Reporting HRCT Findings for ILD from a Multidisciplinary Team

SMA: Data, Insights and Practice

From Bench to Bedside: Gene Therapy Approaches for Rare Diseases

The Importance of Early Integration of Palliative Care

Emerging Treatments for NTM Lung Disease

Nontuberculous Mycobacteria Case 2: Alan

Treatment Challenges with MAC Lung Disease

Nontuberculous Mycobacteria: Summary

Treatment Challenges with MABC Lung Disease

Nontuberculous Mycobacteria Case 1: Maria

NTM – To Treat or Not to Treat

Goals of NTM Treatment

Guideline-recommended Treatments for NTM

Diagnosis of NTM

Factors Associated with Respiratory Involvement in NTM

Most Common Species in NTM Lung Disease

Nontuberculous Mycobacteria: Introduction and Epidemiology

What’s New in Spinal Muscular Atrophy? Reporting from Dallas

New Therapies, New Opportunities and New Challenges in Managing NTM

Updates in Inoperable CTEPH

SMA Updates from Los Angeles

Achieving Better Control of Severe Asthma

Updates in SMA and Gene Therapy from Arlington, VA

Proper_Use_of_an_Inhaler_264x150

Proper Use of an Inhaler

biosims-gastro2

Biosimilars and Patients with Inflammatory Bowel Disease

Nontuberculous Mycobacterial Lung Disease Today and Tomorrow

Exploring the Patient Journey with Problem-Based Learning

Genetics and Personalized Medicine for Patients with Pulmonary Fibrosis

Environmental Influences on the Development of Pulmonary Fibrosis

Gene Abnormalities and ILD

Exploring the Basic Mechanisms that Contribute to Development of Lung Fibrosis

Updates on Registry Enrollment and Growth of the Care Center Network

New Approaches to the Diagnosis of IPF

Exploring New Therapeutic Avenues for Managing PF

New Research on Mechanisms in the Development of PF

biosims-gastro1

Biosimilars: The New Era of Gastroenterology Management Considerations

Know Before You Go: IPF Grand Rounds Pre-learning

IPF Management Considerations

Perspectives on Side Effect Management

The Latest in IPF: Implications for Clinical Practice

Registry Data Provide Important Severity Indicators for PH

New Developments in the Diagnosis and Management of IPF

Palliative Care for Patients with IPF

Real World Experience in Patients with COPD

ICD-10 Codes and Nomenclature for Classification of PAH

Fleischner Society Update in Classification of IPF

Transbronchial Cryobiopsy for the Diagnosis of ILD

psoriasis-nurse

Psoriasis Management Considerations: What Would You Do?

psoriasis-case3

Jamie Develops Complications with Her Psoriasis

psoriasis-case2

Psoriasis: Three Case Studies in the Primary Care Setting

psoriasis-case1

Cindy Has a Complex Case of Psoriasis

Optimizing Patient Outcomes in IPF

Understanding IPF as a Part of the Overall Scope of ILD

Famous People with Diabetes: Ella Fitzgerald

Famous People with Diabetes: Jerry Garcia

Targeting B-cells in Primary Progressive MS (PPMS)

Comorbidities and Selection of DMTs

The Gut Microbiota in MS

Page 6 of 7